Current Opinion in Neurology

Papers
(The TQCC of Current Opinion in Neurology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation71
Management of neuropsychiatric symptoms in dementia56
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis53
The recent surge of functional movement disorders: social distress or greater awareness?42
Chemotherapy and targeted therapies for meningiomas: what is the evidence?42
The role of the gut microbiome in Alzheimer's disease pathophysiology40
Update on management of cerebral venous thrombosis40
Historical development and contemporary use of neuromodulation in human spinal cord injury40
Hereditary motor neuropathies38
From basic mechanisms to therapeutic perspectives in cluster headache37
Editorial introductions31
Central nervous system adverse events of immune checkpoint inhibitors29
Neurology education in the era of artificial intelligence28
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies28
The 2021 WHO classification of central nervous system tumors: what neurologists need to know27
Editorial: Epilepsy advances in 202324
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies24
Microglia in multiple sclerosis – pathogenesis and imaging24
Gene therapies for CMT neuropathies: from the bench to the clinic24
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes23
Editorial introductions22
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise21
Development of neural repair therapy for chronic spinal cord trauma: soluble nogo receptor decoy from discovery to clinical trial21
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection20
Multiple sclerosis in China: the current state of diagnosis and management20
Updates in neuro-otology20
Connecting tremors – a circuits perspective19
Editorial: Modern Gestalt approach to neuromuscular disorders: time for a precision Gestalt19
Threat of resurgence or hope for global eradication of poliovirus?18
Clinical impact of molecular profiling in rare brain tumors18
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management18
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment18
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery18
Thymectomy in myasthenia gravis18
Update on the clinical and therapeutic aspects of myotonic dystrophy type 117
The FSHD jigsaw: are we placing the tiles in the right position?17
Idiopathic intracranial hypertension: expanding our understanding17
Migraine in women: a review17
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke17
Levodopa infusion therapies for Parkinson disease17
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms17
MRI for the diagnosis of limb girdle muscular dystrophies16
Editorial: Advances in neuro-oncology: stepping in the right direction16
fMRI-based spatio-temporal parcellations of the human brain16
Diet and migraine: what is proven?16
Gauging and controlling excitability in cortical disorders16
Obesity-related neuropathy: the new epidemic15
Acute stroke care in low and middle-income countries15
Electrical stimulation of the peripheral and central vestibular system15
Red flags in multiple sclerosis15
Editorial: The gap between academic advances and therapy development in motor neuron disease14
Update on dermatomyositis14
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis14
Parkinson's disease – genetic cause14
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications13
Novel approaches to treatment of leptomeningeal metastases13
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis13
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers13
Progress in spinal muscular atrophy research13
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies13
Targeting IDH1/IDH2 mutations in gliomas13
Visually induced dizziness13
Neuromuscular junction disorders beyond myasthenia gravis13
New developments in diagnostics and treatment of adult-onset focal dystonia13
Optic neuritis: current challenges in diagnosis and management13
Neuroinflammation and immunometabolism in neurodegenerative diseases13
Recent advances in Alzheimer disease genetics13
Monitoring multiple sclerosis: digital and fluid phase biomarkers12
Fluid phase biomarkers in multiple sclerosis12
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management12
Abnormal energy metabolism in ALS: a key player?12
Update on genetics of amyotrophic lateral sclerosis12
Diagnosing viral encephalitis and emerging concepts12
Recent insights in striated muscle laminopathies12
The state of art on the use of patient reported outcomes in migraine12
Current trend in air pollution exposure and stroke11
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease11
Advanced neuroimaging techniques in epilepsy11
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection11
Editorial: Making the invisible visible: updates on vestibular neurology11
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health11
Update on modifiable risk factors for Alzheimer's disease and related dementias11
Pharmacotherapy of cerebellar and vestibular disorders10
Imaging cortical lesions in multiple sclerosis10
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum10
Current gaps in acute reperfusion therapies10
Editorial: Seizure disorders: 2023 update10
Muscle ultrasound in myopathies10
Long COVID and especially headache syndromes10
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders10
Progression in multiple sclerosis – a long-term problem9
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients9
Immune checkpoint inhibitors induced side effects of the peripheral nervous system9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period9
Peripheral visual field loss and activities of daily living9
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review9
Editorial: Cerebrovascular disease9
Motion sickness: current concepts and management9
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases9
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies9
Nonneurologic causes of binocular diplopia for the neurologist9
0.28479599952698